Terazosin Hydrochloride Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 1 mg, 2 mg, 5 mg, 10 mg
Reference Brands: Hytrin (USA)
Category:
Hypertension
Terazosin hydrochloride is available in Tablets
and strengths such as 1 mg, 2 mg, 5 mg, 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Terazosin hydrochloride is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Terazosin hydrochloride can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Terazosin hydrochloride is a medication sold under the brand name Hytrin and belongs to the class of alpha-adrenergic blockers. It is primarily used to treat urinary problems associated with an enlarged prostate (benign prostatic hyperplasia) by relaxing the smooth muscle in the prostate and bladder neck, which helps improve urine flow and reduce symptoms such as difficulty in urination or frequent urination.
In addition to its use for prostate-related urinary issues, terazosin hydrochloride is also prescribed for the management of high blood pressure. By relaxing the smooth muscle in blood vessels, it helps lower blood pressure and improve circulation. The drug is being studied for potential applications in other conditions related to smooth muscle relaxation. Terazosin offers a dual therapeutic benefit by addressing both urinary and cardiovascular conditions through its alpha-blocking mechanism.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing